Leukic
Muscletech Leukic
Muscletech Leukic short for L-leucine-ketoisocaproic acid activates the muscle machinery in the body that is responsible for transmitting your body's STRONGEST anabolic musclebuilding signal - but without increasing or decreasing hormonal levels.
Each serving of Muscletech Leukic is packed with a clinically proven 7.2-gram dose of a unique proprietary compound designed to throw your body into high anabolic gear. One study in the reknowned American Journal of Physiology, Endocrinology and Metabolism found that a key ingredient in Muscletech Leukic has anabolic effects on protein metabolism by increasing the rate of protein synthesis and decreasing the rate of protein degradation in human skeletal muscle after resistance training. This is because MUSCLETECH LEUKIC bypasses the hormone/receptor complex, and flips the anabolic switch directly, which puts the muscle in an immediate anabolic state.
Add MUSCLETECH LEUKIC - the purest, most powerful, most effective anabolic activator in supplement history to your supplement regimen today and get ready to grow like never before!
> 30 Servings Per 180 Capsule Container
Directions for Leukic: As a dietary supplement, take 1 serving (6 caplets) first thing in the morning. On workout days, take 1 serving immediately before your workout. For extreme results, take twice a day. Consume ten 240ml glasses of water daily for general good health. Read the entire label before use and follow directions.
INGREDIENTS: Hydroxyprpoyl cellulose, Microcrystalline cellulose, Croscarmellose sodium, Calcium carbonate, Vegetable stearine, Magnesium stearate, Silica, Magnesium silicate, Leucoattm coating (Polyvinyl alcohol, Polethylene glycol, Talc, Titanium dioxide, Riboflavin, FD&C Red No. 40, FD&C Yellow No. 6, FD&C Blue No. 2, Hydroxypropyl cellulose, Soy lecithin, Polysorbate 80), Hydroxypropyl methylcellulose, Lysin ketoisocaprioc acid, Acesulfame-potassium.
Alternative products:HMB 1000, Leu-MX.
RRP £59.99 £47.99 (Save £12.00)
This item qualifies for free delivery.


